欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Proteasome/Ubiquitin-Heat Shock Protein (HSP)-HVH-2930
HVH-2930

Chemical Structure : HVH-2930

CAS No.:

HVH-2930 (HVH2930)

货号: PC-22212Not For Human Use, Lab Use Only.

HVH-2930 is a specfiic small molecule C-terminal HSP90 inhibitor with SPR KD of 97.2 uM (HSP90α), reduces cell viability and induces apoptosis in HER2-positive breast cancer cells, targets the C-terminal HSP90 without inducing heat shock response (HSR).

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

HVH-2930 is a specfiic small molecule C-terminal HSP90 inhibitor with SPR KD of 97.2 uM (HSP90α), reduces cell viability and induces apoptosis in HER2-positive breast cancer cells, targets the C-terminal HSP90 without inducing heat shock response (HSR).
HVH-2930 effectively inhibited the activity of C-terminal HSP90 by competitively interfering with the binding capability of the co-chaperone PPID, similar to the well-characterized C-terminal HSP90 inhibitor novobiocin.
HVH-2930 dose-dependently reduces cell viability in both trastuzumab-sensitive [BT474 and SKBR3] and -resistant cells [JIMT-1 and MDA-MB453] with IC50 of 6.86 μM, 5.13 μM, 3.94 and 3.93 μM, respectively.
HVH-2930 shows much more higher affinity than novobiocin.
HVH-2930 is a potent C-terminal hHSP90 inhibitor because it not only inhibits the binding of ATP but also stabilizes its open conformation.
HVH-2930-induced apoptosis is accompanied by activation of effector caspases and mitochondrial dysfunction.
HVH-2930 suppresses the HER2 signaling pathway by degrading HSP90 clients.
HVH-2930 inhibits tumor growth of trastuzumab-resistant JIMT-1 xenografts, attenuates CSC-like properties in HER2-positive breast cancer cells.

物理化学性质&存储条件

分子量 488.63
分子式 C29H36N4O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

5-methoxy-2,2-dimethyl-N-(3-methyl-1-(2-(1-methylpiperidin-4-yl)ethyl)-1H-indazol-6-yl)-2H-chromene-6-carboxamide

参考文献

1. Minsu Park, et al. Theranostics. 2024 Mar 31;14(6):2442-2463

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: